title: Transforming growth factor beta 1 stimulates inorganic pyrophosphate elaboration by porcine cartilage.
abstract: The overproduction of inorganic pyrophosphate (PPi) by cartilage is thought to be a key element in the formation of calcium pyrophosphate dihydrate (CPPD) crystals in joints, and the subsequent development of pseudogout or chondrocalcinosis. We report herein that transforming growth factor beta 1 (TGF beta 1), alone and in synergy with epidermal growth factor (EGF) or TGF alpha, markedly stimulates PPi elaboration by porcine articular cartilage in organ culture and monolayer culture. This effect is not seen with platelet-derived growth factor, basic fibroblast growth factor, or insulin-like growth factor types 1 and 2, substances which also affect chondrocyte metabolism or are mitogenic. TGF beta 1 produces only a modest increase in nucleoside triphosphate pyrophosphohydrolase (NTPPPH), a chondrocyte ectoenzyme that produces PPi; this implies the existence of other pathways for PPi elaboration. TGF beta 1 is present in joint fluid and cartilage. TGF beta 1, TGF alpha, and EGF are the first known physiologic modifiers of cartilage PPi production. They provide a novel model for the study of CPPD crystal formation in cartilage, as well as new insights into the pathogenesis of this common affliction of aging.
authors.affiliation: Department of Medicine, Medical College of Wisconsin, Milwaukee.
authors.forename: A K
authors.initials: AK
authors.lastname: Rosenthal
authors.forename: H S
authors.initials: HS
authors.lastname: Cheung
authors.forename: L M
authors.initials: LM
authors.lastname: Ryan
mesh_terms: D000818:Animals; D002358:Cartilage, Articular / Q000166:cytology / Q000201:enzymology / Q000378:metabolism*; D002478:Cells, Cultured; D011756:Diphosphates / Q000378:metabolism*; D004357:Drug Synergism; D004815:Epidermal Growth Factor / Q000494:pharmacology; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D009924:Organ Culture Techniques; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D011755:Pyrophosphatases / Q000378:metabolism; D013002:Somatomedins / Q000494:pharmacology; D013552:Swine; D016211:Transforming Growth Factor alpha / Q000494:pharmacology; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
chemical_list: D011756:Diphosphates; D010982:Platelet-Derived Growth Factor; D013002:Somatomedins; D016211:Transforming Growth Factor alpha; D016212:Transforming Growth Factor beta; D016222:Fibroblast Growth Factor 2; D004815:Epidermal Growth Factor; D011755:Pyrophosphatases; C021895:nucleoside triphosphate pyrophosphatase